Moderna’s final analysis of our Phase 3 COVE Study is out (median follow-up 5.3 months): •Against COVID-19: 93.2% •Against severe COVID-19: 98.2% •Against death caused by COVID-19: 100%— Chise �������� (@sailorrooscout) August 5, 2021
Moderna’s final analysis of our Phase 3 COVE Study is out (median follow-up 5.3 months): •Against COVID-19: 93.2% •Against severe COVID-19: 98.2% •Against death caused by COVID-19: 100%
08-05-2021, 04:12 PM
